Dr. Bader Beteiligungs

Dr. Bader Beteiligungs GmbH is a German investment and holding company based in Mainz, primarily focused on the life sciences and biotechnology sectors. The company is notably recognized as an early-stage investor in c-LEcta, a leading industrial biotechnology firm specializing in enzyme engineering that was acquired by Kerry Group in 2022. It is closely associated with Dr. Augustinus Bader, a world-renowned scientist in stem cell biology and regenerative medicine, and serves as a vehicle for his scientific and business investments. The company supports the development of innovative biotechnological solutions, particularly in fields such as enzyme technology and regenerative medicine. Through its strategic participations, Dr. Bader Beteiligungs plays a role in the commercialization of advanced biotech research in the European market.